Das Augusta-Krankenhaus ist eine Akutklinik in Düsseldorf-Oberrath. Es vereint alle für die Diagnostik und Behandlung notwendigen Fachkliniken unter einem Dach. Das Haus verfügt über 163 Betten, hat 420 Mitarbeiter und behandelt jährlich rund 30.000 Patienten.

During the past decade, Augusta Krankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Augusta Krankenhaus" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Silk Road Medical" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Medtronic Endovascular" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta Krankenhaus" #1 collaborator was "Biotronik, Inc." with 1 trials as a collaborator and "Pharmaceutical Research Associates" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Augusta Krankenhaus" are "Heart Failure" (2 trials), "Angioplasty" (1 trials), "Arterial Occlusive Diseases" (1 trials), "Carotid Artery Diseases" (1 trials) and "Coronary Heart Disease" (1 trials). Many other conditions were trialed in "Augusta Krankenhaus" in a lesser frequency.

Most popular intervention types in "Augusta Krankenhaus" are "Device" (7 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "ByCross Atherectomy and Thrombectomy" (1 trials), "Coronary artery stenting" (1 trials), "Device Programming of the Boston Scientific Cardiac Resynchronization Therapy Defibrillator (CRT-D)" (1 trials), "IN.PACT Admiral™ Drug Eluting Balloon" (1 trials) and "MICHI(TM) NPS+f" (1 trials). Other intervention names were less common.

The vast majority of trials in "Augusta Krankenhaus" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Augusta Krankenhaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Augusta Krankenhaus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Augusta Krankenhaus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".